CURRENT ISSUE Current Issue Cover
VOL 7 • NUM 4 MAY/JUN 2016
IN THIS ISSUE

Value and Financial Toxicity of New Cancer Drugs

Rita J. Wickham, PhD, RN, AOCN®

Beyond BRCA: A Pilot Program to Assess and Improve Knowledge of Pharmacogenomic Testing Among Advanced Practitioners in a Breast Cancer Treatment Setting

Samuel L. Hoffman,(1) DNP, RN, Robert Reid Kaufman,(2) PharmD, Shannon Ferrari,(3) PA-C, MPAS, Sheila Ann Alexander,(2) PhD, RN, FCCM, Margaret Quinn Rosenzweig,(2) PhD, CRNP-C, AOCN®, FAAN, and Susan W. Wesmiller,(4) PhD, RN

Continuing Education Information: Multigene Panel Testing for Hereditary Cancer Risk

Alyssa A. Grissom, MSN, APN, AGCNS, OCN®, and Patricia J. Friend, PhD, APN-CNS, AOCNS®, AGN-BC

Multigene Panel Testing for Hereditary Cancer Risk

Alyssa A. Grissom, MSN, APN, AGCNS, OCN®, and Patricia J. Friend, PhD, APN-CNS, AOCNS®, AGN-BC

 
Section Seperator

TODAY'S NEWS

At Cancer Moonshot Summit, Vice Presiden...

Today, the Cancer Moonshot hosted a summit at Howa...

Richard Pazdur, MD, Named Acting Directo...

U.S. Food and Drug Administration (FDA) Commission...

FDA Approves Sofosbuvir/Velpatasvir for ...

On June 28, the U.S. Food and Drug Administration ...

ASCO Outlines Opposition to Medicare Par...

ASCO voiced its strong opposition to the proposed ...

Study Finds Addition of High-Dose Cytara...

The phase III European MCL Younger trial has shown...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Granulocyte Transfusions in Neutropenia

Among patients with cancer, many factors can cause severe and persistent neutropenia...

Optimizing the Teachable Moment for Survivors

Due to significant advances in screening, detection, and treatment, 70% of patients with cancer are living 5 years or longer...

Ruxolitinib in Myelofibrosis and Polycythemia Vera

Myelofibrosis and polycythemia vera are BCR-ABL1-negative subtypes of chronic myeloproliferative neoplasms...

Trifluridine/Tipiracil: Old Drug, New Tricks

Colorectal cancer is the third most commonly diagnosed cancer in the U.S...

Assessment of Constipation in Patients With Cancer

Constipation, a significant problem for many cancer patients, often leads to significant distress...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

No Overall Advantage to Adding Pertuzuma...

According to a European phase III trial reported i...

Ipilimumab Combined With Antigen-Specifi...

In a study reported in the <em>Journal of Cl...

CAP, IASLC, and AMP Seek Public Comments...

The College of American Pathologists (CAP), the In...

Nivolumab Receives FDA Breakthrough Ther...

Bristol-Myers Squibb Company announced June 27 tha...

Reduced-Intensity Transplantation With H...

Patients with lymphoma undergoing reduced-intensit...

More Highlights More Highlights
 
Section Seperator
Section Seperator
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here